Skip to main content
F

Formosa Laboratories, Inc. — Investor Relations & Filings

Ticker · 4746 TW Manufacturing
Open in API
Filings indexed 1,856 across all filing types
Latest filing 2026-04-07 Regulatory Filings
Country TW Taiwan
Listing TW 4746

About Formosa Laboratories, Inc.

https://www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
115年3月背書保證與資金貸與
Regulatory Filings Classification · 1% confidence The provided text is an error/security page indicating the document cannot be accessed, containing no financial or regulatory content. It does not match any specific filing category and thus falls into the fallback category.
2026-04-07 Chinese
115年3月營業收入
Regulatory Filings Classification · 1% confidence The document is an error page stating that the page cannot be accessed, with no financial content or filing information. It does not match any specific filing category and falls under the fallback category for miscellaneous regulatory announcements.
2026-04-07 Chinese
115年03月內部人持股異動(事後)
Regulatory Filings Classification · 0% confidence The provided text is merely an access error message and contains no substantive corporate filing content or announcements. It does not match any specific filing category definitions. As a non-standard document with no reporting details, it falls under the general fallback category for miscellaneous regulatory filings.
2026-04-07 Chinese
115年03月董事會成員及持股
Director's Dealing Classification · 1% confidence The document is a regulatory table listing insider (directors, independent directors, supervisors, senior management) shareholdings, current holdings vs initial holdings, pledged shares and related ratios. This is an insider shareholding disclosure rather than an investor presentation or financial report. It corresponds to reporting of directors’ personal share transactions/holdings under insider dealing regulations. Therefore, it should be classified as Director’s Dealing (DIRS).
2026-04-07 Chinese
114年度財務比率
Regulatory Filings
2026-03-25 Chinese
114年第4季海外子公司投資
Regulatory Filings
2026-03-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.